Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis

Leukemia

Volumn 25, Issue 8, 2011, Pages 1232-1238

  Teuffel, O ^a   Kuster, S P ^b   Hunger, S P ^c   Conter, V ^d,e   Hitzler, J ^a   Ethier, M C ^a   Shah, P S ^b,f   Beyene, J ^f,g   Sung, L ^a,f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d SAN GERARDO HOSPITAL   (Italy)

^e OSPEDALI RIUNITI   (Italy)

^f UNIVERSITY OF TORONTO   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

childhood leukemia; corticosteroids; toxicity; treatment

Indexed keywords

DEXAMETHASONE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CHILDHOOD CANCER; DIABETES MELLITUS; DRUG EFFICACY; DRUG FATALITY; HUMAN; INFORMATION PROCESSING; META ANALYSIS; MORTALITY; MYCOSIS; MYOPATHY; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SYSTEMATIC REVIEW;

CHILD; DEXAMETHASONE; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE;

EID: 80051793838     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.84     Document Type: Review

References (40)

1. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-1043. (Pubitemid 351389536)
2. Pui CH. Childhood Leukemias, 2nd edn. Cambridge University Press: New York, NY, 2006.
3. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178. (Pubitemid 43076714)
4. Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010;24:265-284.
5. Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN et al. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 2010;24:285-297.
6. Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 2003;101:3809-3817. (Pubitemid 36857851)
7. Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 2005;129:734-745. (Pubitemid 40904523)
8. Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y et al. No advantage of dexamethasone over prednisolone for the outcome of standard-and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol. J Clin Oncol 2005;23:6489-6498. (Pubitemid 46190240)
9. Bertrand Y, Suciu S, Benoit Y, Robert A, Nelken B, Uyttebroeck A et al. Dexamethasone (DEX) (6 mg/sm/d) and prednisolone (PRED) (60 mg/sm/d) in induction therapy of childhood ALL are equally effective: results of the 2nd Interim Analysis of EORTC Trial 58951. Blood (ASH Annu Meet Abstr) 2008;112:8.
10. McNeer JL, Nachman JB. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol 2010;149:638-652.
11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
12. Taketomo CK. Pediatric Dosage Handbook International, 13th edn. LEXI-COMP: Hudson, OH, 2006.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174. (Pubitemid 8054849)
14. Schrappe M, Zimmermann M, Moricke A, Mann G, Valsecchi MG, Bartram CR et al. Dexamethasone in induction can eliminate one third of all relapses in childhood acute lymphoblastic leukemia (ALL): results of an international randomized trial in 3655 patients (Trial AIEOP-BFM ALL 2000). Blood (ASH Annu Meet Abstr) 2008;112:7.
15. Mattano Jr LA, Nachman JB, Devidas M, Winick N, Raetz E, Carroll WL et al. Increased incidence of osteonecrosis (ON) with a dexamethasone (DEX) induction for high risk acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group (COG). Blood (ASH Annu Meet Abstr) 2008;112:898.
16. Moricke A, Zimmermann M, Schrauder A, Stanulla M, Schmid H, Fengler R et al. No influence on the incidence of osteonecroses when dexamethasone replaces prednisone during induction treatment for childhood ALL: results of Trial ALL-BFM 2000. Blood (ASH Annu Meet Abstr) 2008;112:899-89.
17. Higgins J P T, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from http://www.cochrane-handbook.org.
18. Gaynon PS, Lustig RH. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations. J Pediatr Hematol Oncol 1995;17:1-12.
19. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977;63:200-207. (Pubitemid 8160340)
20. Borenstein M, Hedges VH, Higgins J P T, Rothstein HR. Introduction to Meta-Analysis. Wiley: Chichester, West Sussex, 2009.
21. Sutton AJ, Duval SJ, Tweedie RL. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000;320:1574-1577. (Pubitemid 30336090)
22. Jones B, Freeman AI, Shuster JJ, Jacquillat C, Weil M, Pochedly C et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991;19:269-275.
23. Ahmed SF, Tucker P, Mushtaq T, Wallace AM, Williams DM, Hughes IA. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Clin Endocrinol 2002;57:185-191. (Pubitemid 34989094)
24. Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C et al. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;50:537-541. (Pubitemid 351155821)
25. Eiser C, Davies H, Jenney M, Stride C, Glaser A. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2006;46:35-39. (Pubitemid 41779315)
26. Kadan-Lottick NS, Brouwers P, Breiger D, Kaleita T, Dziura J, Liu H et al. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 2009;114:1746-1752.
27. Karachunskiy A, Olga A, Ralf H, Arend von S, Julia R, Larisa F et al. Preliminary results of the Multicenter Randomised Trial All-Mb (Moscow-Berlin) 2002 for childhood acute lymphoblastic leukemia in Russia and Belarus. SIOP Meeting (Conference Abstract) Berlin, Germany, 2008, p 31.
28. Labar B, Suciu S, Willemze R, Muus P, Marie JP, Fillet G et al. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. Haematologica 2010;95:1489-1495.
29. Marino S, Verzegnassi F, Tamaro P, Stocco G, Bartoli F, Decorti G et al. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. Pediatr Blood Cancer 2009;53:984-991.
30. Mitchell C, Payne J, Wade R, Vora A, Kinsey S, Richards S et al. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99. Br J Haematol 2009;146:424-436.
31. Nowak-Gottl U, Ahlke E, Fleischhack G, Schwabe D, Schobess R, Schumann C et al. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood 2003;101:2529-2533. (Pubitemid 36857608)
32. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, Gibson BE. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 2001;86:3742-3745. (Pubitemid 32755970)
33. Roy A, Bradburn M, Moorman AV, Burrett J, Love S, Kinsey SE et al. Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial. Br J Haematol 2005;129:35-44. (Pubitemid 40524049)
34. Saracco P, Bertorello N, Farinasso L, Einaudi S, Barisone E, Altare F et al. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase. J Pediatr Hematol Oncol 2005;27:141-144. (Pubitemid 40397243)
35. [Erratum appears in J Pediatr Hematol Oncol 2005;27(4):242. Note: Corrias, Andrea [added]].
36. Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ et al. Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. J Clin Oncol 2001;19:1040-1046. (Pubitemid 32176279)
37. Sirvent N, Suciu S, Benoit Y, Bertrand Y, Nelken B, Robert A et al. Prognostic significance of central nervous system (CNS) status of children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group Study 58951. Blood (ASH Annu Meet Abstr) 2008;112:303.
38. Wallace AM, Tucker P, Williams DM, Hughes IA, Ahmed SF. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol 2003;58:770-776. (Pubitemid 36702738)
39. Kaspers GJ, Veerman AJ, Popp-Snijders C, Lomecky M, Van Zantwijk CH, Swinkels LM et al. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1996;27:114-121. (Pubitemid 26200153)
40. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987;5:202-207. (Pubitemid 17021600)